Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Denk

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 8, 2018
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosisSimon Hohenester, Simon Christiansen, Jutta Nagel, et al.
Cells|August 12, 2022
Hydrophobic Bile Salts Induce Pro-Fibrogenic Proliferation of Hepatic Stellate Cells through PI3K p110 Alpha SignalingSebastian Zimny, Dennis Koob, Jingguo Li, et al.
Cardiovascular Diagnosis and Therapy|May 10, 2021
Congenital heart disease-associated liver disease: a narrative reviewFlorian P Reiter, Nino J Hadjamu, Nicole Nagdyman, et al.
Frontiers in Endocrinology|February 9, 2023
Evolution of non-thyroidal illness syndrome in acute decompensation of liver cirrhosis and acute-on-chronic liver failureMona-May Langer, Alina Bauschen, Sabrina Guckenbiehl, et al.
European Journal of Nutrition|March 12, 2022
Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patientsMonika Bischoff, Sebastian Zimny, Sebastian Feiner, et al.
Journal of Gastroenterology and Hepatology|November 4, 2022
Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HClIsabelle Mohr, Hélène Bourhis, France Woimant, et al.
Orphanet Journal of Rare Diseases|May 24, 2023
Medical care of patients with Wilson disease in Germany: a multidisciplinary survey among university centersSebastian Zimny, Hélène Bourhis, Sabine Weber, et al.
Digestive Diseases (Basel, Switzerland)|June 11, 2020
Prevalence, Resistance Rates, and Risk Factors of Pathogens in Routine Bile Cultures Obtained during Endoscopic Retrograde CholangiographyFlorian P Reiter, Wolfgang Obermeier, Jette Jung, et al.
Cells|January 26, 2020
Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular CholestasisSimon Hohenester, Veronika Kanitz, Andreas E Kremer, et al.
Digestive Diseases (Basel, Switzerland)|October 13, 2021
Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art ReviewFlorian P Reiter, Najib Ben Khaled, Liangtao Ye, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 8, 2018
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosisSimon Hohenester, Simon Christiansen, Jutta Nagel, et al.
Cells|August 12, 2022
Hydrophobic Bile Salts Induce Pro-Fibrogenic Proliferation of Hepatic Stellate Cells through PI3K p110 Alpha SignalingSebastian Zimny, Dennis Koob, Jingguo Li, et al.
Cardiovascular Diagnosis and Therapy|May 10, 2021
Congenital heart disease-associated liver disease: a narrative reviewFlorian P Reiter, Nino J Hadjamu, Nicole Nagdyman, et al.
Frontiers in Endocrinology|February 9, 2023
Evolution of non-thyroidal illness syndrome in acute decompensation of liver cirrhosis and acute-on-chronic liver failureMona-May Langer, Alina Bauschen, Sabrina Guckenbiehl, et al.
European Journal of Nutrition|March 12, 2022
Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patientsMonika Bischoff, Sebastian Zimny, Sebastian Feiner, et al.
Journal of Gastroenterology and Hepatology|November 4, 2022
Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HClIsabelle Mohr, Hélène Bourhis, France Woimant, et al.
Orphanet Journal of Rare Diseases|May 24, 2023
Medical care of patients with Wilson disease in Germany: a multidisciplinary survey among university centersSebastian Zimny, Hélène Bourhis, Sabine Weber, et al.
Digestive Diseases (Basel, Switzerland)|June 11, 2020
Prevalence, Resistance Rates, and Risk Factors of Pathogens in Routine Bile Cultures Obtained during Endoscopic Retrograde CholangiographyFlorian P Reiter, Wolfgang Obermeier, Jette Jung, et al.
Cells|January 26, 2020
Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular CholestasisSimon Hohenester, Veronika Kanitz, Andreas E Kremer, et al.
Digestive Diseases (Basel, Switzerland)|October 13, 2021
Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art ReviewFlorian P Reiter, Najib Ben Khaled, Liangtao Ye, et al.
Pageof 6